(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TESTAGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TESTAGEN

ST13

US500000085760169

Class

1

Filing

85760169

Registration

4350197

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

11/02/2023

Trademark type

Word

Nice classes

1

Filing date

10/22/2012

Registration date

06/11/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/02/2023

Last transaction

11/02/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

01/01/2005

First use in commerce

02/01/2011

Drawing code

4

Owner type

03

Owner location

Palm Beach Gardens, FL

Examiner

SINGH, TEJBIR

Law office

L60

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Transdermal Delivery Solutions Corp.

Representatives

Transdermal Delivery Solutions Corp.

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating hormone deficiencies.; Chemical additives for use in the manufacture of hormone replacement products; Excipients for use in the manufacture of pharmaceutical preparations

Publications

History of USPTO decisions and trademark events.

24 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/02/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/02/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/02/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/02/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

05/08/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/11/2022

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/14/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/14/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

11/20/2019

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

11/19/2019

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

11/06/2019

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

06/21/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/21/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/13/2019

E815

TEAS SECTION 8 & 15 RECEIVED

05/13/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/11/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

06/11/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/26/2013

PUBO

PUBLISHED FOR OPPOSITION

03/26/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/06/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/20/2013

DOCK

ASSIGNED TO EXAMINER

02/20/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/25/2012

NWAP

NEW APPLICATION ENTERED

10/25/2012

Continuous trademark protection

Get notified about every new filing that threatens TESTAGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.